| Formulary Chapter 3: Respiratory system - Full Chapter
|
| 03.12 |
Oscillating Positive Expiratory Pressure devices |
|
|
PARI O-PEP®
(device)
|
First Choice
|
Oscillating Positive Expiratory Pressure (OPEP) device.
 For initiation by specialist physiotherapist or respiratory clinician only. For airways clearance in selected patients with chronic sputum-producing lung disease, e.g. cystic fibrosis, bronchiectasis, COPD.
All follow up and monitoring of patients, and routine replacement of devices to be carried out in secondary care.
Primary care prescribing on FP10 only when required for urgent supply of additional/replacement device (Drug Tariff listed approved appliance).
|
Aerobika®
(device)
|
Second Choice
|
Oscillating Positive Expiratory Pressure (OPEP) device.
Second-line, for patients unsuitable for PARI O-PEP device.
For initiation by specialist physiotherapist or respiratory clinician only. For airways clearance in selected patients with chronic sputum-producing lung disease, e.g. cystic fibrosis, bronchiectasis, COPD.
All follow up and monitoring of patients, and routine replacement of devices to be carried out in secondary care.
Primary care prescribing on FP10 only when required for urgent supply of additional/replacement device (Drug Tariff listed approved appliance).
|
Acapella Choice®
(device)
|
Third Choice
|
Oscillating Positive Expiratory Pressure (OPEP) device.
Third-line, for patients unsuitable for PARI O-PEP or Aerobika device.
For initiation by specialist physiotherapist or respiratory clinician only. For airways clearance in selected patients with chronic sputum-producing lung disease, e.g. cystic fibrosis, bronchiectasis, COPD.
All follow up and monitoring of patients, and routine replacement of devices to be carried out in secondary care.
Primary care prescribing on FP10 only when required for urgent supply of additional/replacement device (Drug Tariff listed approved appliance).
|
Flutter®; LungFlute®; RC-Cornet®
(devices)
|
Non Formulary
|
Oscillating Positive Expiratory Pressure (OPEP) devices.
Following District Prescribing Committee review, not supported for routine use locally, although may be considered for individual patients in exceptional circumstances if formulary options are unsuitable.
|
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Traffic Light Status Information
| Status |
Description |
|
Suitable for prescribing by all in both primary and secondary care. |
|
Specialist recommended but suitable for continuation in primary care. |
|
Specialist initiated but suitable for continuation in primary care. |
|
Specialist initiated and for continuation in primary care under a locally approved shared care guideline. |
|
Suitable for prescribing in specialist settings (secondary care) only. |
|
Secondary care medicines to be used under specialised commissioning arrangements only. |
|
For primary care, either via FP10 or supplied through specialist services. These products may be stocked by hospital
pharmacies only for supply to primary care units/wards or for continuing supplies for patients admitted on therapy. |
|
Not recommended for use. |
|
|
